75 related articles for article (PubMed ID: 36241236)
1. Efficacy of fertility-sparing treatment with LNG-IUS is associated with different ProMisE subtypes of endometrial carcinoma or atypical endometrial hyperplasia.
Lv X; Guo L; Wang C
J Gynecol Oncol; 2024 May; 35(3):e27. PubMed ID: 38216133
[TBL] [Abstract][Full Text] [Related]
2. Oncologic, fertility, and obstetric outcomes with MPA therapy in women with endometrial cancer and atypical endometrial hyperplasia.
Takeda A; Yamamoto Y; Tamura K; Aoki H; Noguchi H; Minato S; Kamada S; Arakaki R; Kaji T; Iwasa T
J Obstet Gynaecol Res; 2024 Apr; 50(4):633-638. PubMed ID: 38154145
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy and obstetric outcomes after fertility-sparing management of endometrial cancer and atypical hyperplasia: a multicentre cohort study.
Vasileva R; Wohrer H; Gaultier V; Bucau M; Courcier H; Ben Miled S; Gonthier C; Koskas M
Hum Reprod; 2024 Jun; 39(6):1231-1238. PubMed ID: 38719783
[TBL] [Abstract][Full Text] [Related]
4. Effects of hysteroscopic surgery combined with progesterone therapy on fertility and prognosis in patients with early endometrial cancer and atypical endometrial hyperplasia or endometrial intraepithelial neoplasia: a meta-analysis.
Ye X; Li T
Arch Gynecol Obstet; 2024 Jan; 309(1):259-268. PubMed ID: 37540307
[TBL] [Abstract][Full Text] [Related]
5. Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia.
Zhang Q; Qi G; Kanis MJ; Dong R; Cui B; Yang X; Kong B
Oncotarget; 2017 Aug; 8(34):57642-57653. PubMed ID: 28915701
[TBL] [Abstract][Full Text] [Related]
6. Quality of information and decision regrets during fertility-sparing management for atypical hyperplasia and endometrial cancer in a prospective cohort study.
Grenot M; Vandenbroucke T; Bucau M; Koskas M
J Gynecol Obstet Hum Reprod; 2024 Apr; 53(4):102722. PubMed ID: 38185245
[TBL] [Abstract][Full Text] [Related]
7. The analysis of IVF outcomes after fertility-preserving therapy for endometrial hyperplasia or carcinoma.
Park J; Yu EJ; Lee N; Park JE; Seong SJ; Lee WS; Lee HJ
Gynecol Obstet Invest; 2024 May; ():. PubMed ID: 38768567
[TBL] [Abstract][Full Text] [Related]
8. Metformin and progestins in women with atypical hyperplasia or endometrial cancer: systematic review and meta-analysis.
Adamyan L; Pivazyan L; Isaeva S; Shapovalenko R; Zakaryan A
Arch Gynecol Obstet; 2024 Jun; 309(6):2289-2305. PubMed ID: 38503850
[TBL] [Abstract][Full Text] [Related]
9. Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter-Group (GCIG) study.
Falcone F; Leone Roberti Maggiore U; Di Donato V; Perrone AM; Frigerio L; Bifulco G; Polterauer S; Casadio P; Cormio G; Masciullo V; Malzoni M; Greggi S
J Gynecol Oncol; 2020 Sep; 31(5):e74. PubMed ID: 32808500
[TBL] [Abstract][Full Text] [Related]
10. Conservative re-treatment of women with atypical endometrial hyperplasia and early endometrial carcinoma: We can hope, at least.
Raffone A; Raimondo D; Rovero G; Travaglino A; Lopez G; Di Maio CM; Neola D; Raspollini A; Renzulli F; Filippelli A; Casadio P; Seracchioli R; Guida M
Int J Gynaecol Obstet; 2024 May; 165(2):542-551. PubMed ID: 37772342
[TBL] [Abstract][Full Text] [Related]
11. Fertility Sparing Treatment in Patients With Early Stage Endometrial Cancer, Using a Combination of Surgery and GnRH Agonist: A Monocentric Retrospective Study and Review of the Literature.
Tock S; Jadoul P; Squifflet JL; Marbaix E; Baurain JF; Luyckx M
Front Med (Lausanne); 2018; 5():240. PubMed ID: 30211167
[TBL] [Abstract][Full Text] [Related]
12. Mismatch repair deficiency and abnormal p53 expression has significant predictive value for progesterone resistance and endometrial tumorigenesis in patients with endometrial atypical hyperplasia receiving fertility-preserving treatment.
Peng H; Jiang J; Li L; Hao Z; Lian H; Du H; Wang W
Gynecol Oncol; 2024 Apr; 186():154-160. PubMed ID: 38691985
[TBL] [Abstract][Full Text] [Related]
13. Contemporary Fertility-Sparing Management Options of Early Stage Endometrioid Endometrial Cancer in Young Nulliparous Patients.
Aimagambetova G; Terzic S; Laganà AS; Bapayeva G; la Fleur P; Terzic M
J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011935
[TBL] [Abstract][Full Text] [Related]
14. Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers.
Berg A; Gulati A; Ytre-Hauge S; Fasmer KE; Mauland KK; Hoivik EA; Husby JA; Tangen IL; Trovik J; Halle MK; Stefansson I; Akslen LA; Woie K; Bjørge L; Salvesen HB; Salvesen ØO; Werner HMJ; Haldorsen IS; Krakstad C
Oncotarget; 2017 Sep; 8(40):68530-68541. PubMed ID: 28978135
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of fertility-sparing therapy of patients with complex atypical hyperplasia and endometrial cancer].
Morimoto C; Wang YQ; Zhou R; Wang JL
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):936-942. PubMed ID: 36241236
[TBL] [Abstract][Full Text] [Related]
16. [Effects of pathological assessment of endometrial tissue in fertility-sparing treatment with progestin for endometrial carcinoma of stage I a and complex atypical hyperplasia].
Gong Q; Chen X; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2014 Sep; 49(9):664-9. PubMed ID: 25487452
[TBL] [Abstract][Full Text] [Related]
17. Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.
Simpson AN; Feigenberg T; Clarke BA; Gien LT; Ismiil N; Laframboise S; Massey C; Ferguson SE
Gynecol Oncol; 2014 May; 133(2):229-33. PubMed ID: 24561246
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of prognosis and pregnancy outcomes of fertility-preserving treatment for patients with stage Ⅰa, grade 2 endometrial cancer].
Wang YQ; Zhou R; Xu LJ; Xia M; Lu Q; Liu GL; Shen DH; Wang G; He M; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2020 May; 55(5):327-332. PubMed ID: 32464721
[No Abstract] [Full Text] [Related]
19. Efficacies and pregnant outcomes of fertility-sparing treatment with medroxyprogesterone acetate for endometrioid adenocarcinoma and complex atypical hyperplasia: our experience and a review of the literature.
Ohyagi-Hara C; Sawada K; Aki I; Mabuchi S; Kobayashi E; Ueda Y; Yoshino K; Fujita M; Tsutsui T; Kimura T
Arch Gynecol Obstet; 2015 Jan; 291(1):151-7. PubMed ID: 25118836
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
